Nutraveris
Tuesday, October 4, 2016
Category : News, INGREDIENTS, INNOVATION, CLINICAL EVIDENCE | Author : experts
Tags:

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, informs you:

 

This randomized, double-blinded, crossover and placebo controlled examine the analgesic activity of a single dose of Terminalia chebula in healthy humans. 12 participants have received a placebo or 1 g or Terminalia chebula aqueous extract (≥ 15 % chebulinic acid, ≥ 10% chebulagic acid, ≥ 15% other low molecular weight hydrolysable tannins).

A mechanical pain model was used in this study. Briefly, pain was assessed though a force applied to the nail bed (Randall-Selitto test). Pain threshold (when participant first experiences pain) and pain tolerance (when participant was unable to tolerate pain) were assessed.

graphe-terminalia

 

As shown in the figure, pain threshold has been increased after the T. chebula intake (p < 0.001 vs. placebo), as tolerance force (p < 0.001). Similarly, threshold time and tolerance time have been increased after T. chebula I comparison to placebo (p < 0.001, data not shown). Based on these results, Terminalia chebula may be interesting for pain management, as for instance for osteoarthritis or rheumatoid arthritis.

 

Kumar CU, Pokuri VK, Pingali U. Evaluation of the Analgesic Activity of Standardized Aqueous Extract of Terminalia chebula in Healthy Human Participants Using Hot Air Pain Model.J Clin Diagn Res. 2015 May;9(5):FC01-4.

 

 

This information has been sourced by NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders.

This collaborative and complete tool contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

Formulate new innovative products

Check if your already existing formulas are still compliant with the in force regulations

Adapt your existing formulas to the requirements of other European countries where you are willing to export them

Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…

 

More information on www.nutraveris.com

Contact our Sientific & Regulatory experts at NUTRAVERIS

contact@nutraveris.com, +33 2 96 76 54 87

Leave a Reply